These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2994615)

  • 1. Immunofluorescence and electron microscopic investigations of epithelial hybrid cells derived from nasopharyngeal carcinoma (NPC-KT).
    Takimoto T; Morishita K; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1985; 12(1):37-45. PubMed ID: 2994615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus activation of human epithelial-nasopharyngeal carcinoma hybrid cells.
    Takimoto T; Umeda R; Ogura H; Hatano M
    Am J Otolaryngol; 1984; 5(1):1-6. PubMed ID: 6099983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) receptors on epithelial hybrid cells derived from nasopharyngeal carcinoma.
    Takimoto T; Tanaka S; Ishikawa S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(2):69-74. PubMed ID: 2158034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
    Glaser R; Zhang HY; Yao KT; Zhu HC; Wang FX; Li GY; Wen DS; Li YP
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Takimoto T; Kamide M; Umeda R
    Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T; Sato H; Ogura H; Ogura T; Ishikawa S; Iwawaki J
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(4):169-74. PubMed ID: 2819802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human interferon on cell proliferation and antigens induced by Epstein-Barr virus in epithelial hybrid cells derived from nasopharyngeal carcinoma.
    Takimoto T; Ishikawa S; Umeda R; Ogura H; Hatano M
    Otolaryngol Head Neck Surg; 1985 Aug; 93(4):500-4. PubMed ID: 2995902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma.
    Trumper PA; Epstein MA; Giovanella BC; Finerty S
    Int J Cancer; 1977 Nov; 20(5):655-62. PubMed ID: 200568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).
    Takimoto T; Ogura H; Sato H; Umeda R; Hatano M
    J Natl Cancer Inst; 1985 Jan; 74(1):57-60. PubMed ID: 2982054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
    Takimoto T; Furukawa M; Hatano M; Umeda R
    Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Epstein-Barr virus (EBV) receptor on the surface of cells infected with EBV derived from nasopharyngeal carcinoma.
    Takimoto T; Umeda R
    Acta Virol; 1989 Aug; 33(4):314-9. PubMed ID: 2574937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation in vitro by BUdR of a productive EB virus infection in the epithelial cells of nasopharyngeal carcinoma.
    Trumper PA; Epstein MA; Giovanella BC
    Int J Cancer; 1976 May; 17(5):578-87. PubMed ID: 178612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial characteristics of tumor cells in nasophasyngeal carcinoma.
    de-Thé G; Vuillaume M; Giovanella BC; Klein G
    J Natl Cancer Inst; 1976 Nov; 57(5):1101-5. PubMed ID: 187791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinuclear antibodies in the sera of patients with nasopharyngeal carcinoma.
    Takimoto T; Ishikawa S; Masuda K; Tanaka S; Yoshizaki T; Umeda R
    Am J Otolaryngol; 1989; 10(6):399-403. PubMed ID: 2556945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.